Pharmafile Logo
Pharmafocus logo
Advanced Search

birth

Showing 3 posts of 3 posts found.

AMAG Pharmaceuticals’ shares fall 21% after failed Makena trial

March 11, 2019
Sales and Marketing AMAG Pharmaceuticals, Makena, PROLONG, birth, trials

AMAG Pharmaceuticals’ Makena (hydroxyprogesterone caproate) has failed to meet its co-primary endpoints in a trial of patients with a history …

News
GSK image

GSK premature babies drug starts late-stage trials

March 18, 2015
Sales and Marketing GSK, Retosiban, atosiban, babies, birth, oxytocin, premature

GlaxoSmithKline has initiated Phase III studies to evaluate the safety and efficacy of an investigational treatment for babies born prematurely. …

News
merck image

Merck in $100 million contraceptive settlement

February 10, 2014
Sales and Marketing Merck, birth, birth control, legal, nuvaring

Merck has offered to pay $100 million to resolve thousands of legal claims brought against it for selling a birth …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025